[Federal Register Volume 76, Number 55 (Tuesday, March 22, 2011)]
[Notices]
[Page 15982]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-6702]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a 
meeting. The meeting will be open to the public.

DATES: The meeting will be held on Tuesday and Wednesday, May 10 and 
11, 2011. The meeting will be held from 9 a.m. until 5 p.m. on May 10, 
2011, and 9 a.m. until 4:30 p.m. on May 11, 2011.

ADDRESSES: Department of Health and Human Services; Room 800, Hubert H. 
Humphrey Building; 200 Independence Avenue, SW., Washington, DC 20201. 
For a map and directions to the Hubert H. Humphrey building, please 
visit http://www.hhs.gov/about/hhhmap.html.

FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, DrPH; Executive 
Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of 
Health and Human Services; 200 Independence Avenue, SW., Hubert 
Humphrey Building, Room 712E; Washington, DC 20201. Please direct all 
inquiries to <a href="/cdn-cgi/l/email-protection#bddedbcedcdefdd5d5ce93dad2cb"><span class="__cf_email__" data-cfemail="214247524042614949520f464e57">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. 
The Committee shall advise and make recommendations to the Secretary, 
through the Assistant Secretary for Health, on a broad range of topics 
including (1) the current state of knowledge and research and the 
relevant gaps in knowledge and research about the epidemiology, 
etiologies, biomarkers and risk factors relating to CFS, and 
identifying potential opportunities in these areas; (2) impact and 
implications of current and proposed diagnosis and treatment methods 
for CFS; (3) development and implementation of programs to inform the 
public, health care professionals, and the biomedical academic and 
research communities about CFS advances; and (4) partnering to improve 
the quality of life of CFS patients.
    The agenda for this meeting is being developed. The agenda will be 
posted on the CFSAC Web site, http://www.hhs.gov/advcomcfs, when it is 
finalized. The meeting will be broadcast over the Internet as a real-
time streaming video. It also will be recorded and archived for on 
demand viewing through the CFSAC Web site.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a government-issued photo ID for entry into 
the building where the meeting is scheduled to be held. Those attending 
the meeting will need to sign-in prior to entering the meeting room. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at <a href="/cdn-cgi/l/email-protection#82e1e4f1e3e1c2eaeaf1ace5edf4"><span class="__cf_email__" data-cfemail="8be8edf8eae8cbe3e3f8a5ece4fd">[email protected]</span></a> in advance.
    Members of the public will have the opportunity to provide oral 
testimony at the May 10-11, 2011, meeting if pre-registered. 
Individuals who wish to address the Committee during the public comment 
session must pre-register by Monday, April 18, 2011, via e-mail to 
<a href="/cdn-cgi/l/email-protection#82e1e4f1e3e1c2eaeaf1ace5edf4"><span class="__cf_email__" data-cfemail="e88b8e9b898ba880809bc68f879e">[email protected]</span></a>. Time slots for public comment will be available on a 
first-come, first-served basis and will be limited to five minutes per 
speaker; no exceptions will be made. Individuals registering for public 
comment should submit a copy of their oral testimony in advance to 
<a href="/cdn-cgi/l/email-protection#ed8e8b9e8c8ead85859ec38a829b"><span class="__cf_email__" data-cfemail="056663766466456d6d762b626a73">[email protected]</span></a>, prior to the close of business on Monday, April 18, 
2011.
    If you do not submit your written testimony by the close of 
business Monday, April 18, 2011, you may bring a copy to the meeting 
and present it to a CFSAC Support Team staff member. Your testimony 
will be included in a notebook available for viewing by the public on a 
table at the back of the meeting room.
    Members of the public not providing public comment at the meeting 
who wish to have printed material distributed to CFSAC members for 
review should submit, at a minimum, one copy of the material to the 
Executive Secretary, at <a href="/cdn-cgi/l/email-protection#81e2e7f2e0e2c1e9e9f2afe6eef7"><span class="__cf_email__" data-cfemail="9af9fce9fbf9daf2f2e9b4fdf5ec">[email protected]</span></a>, prior to close of business on 
Monday, April 18, 2011. Submissions are limited to five typewritten 
pages. If you wish to remain anonymous, please notify the CFSAC support 
team upon submission of your materials to <a href="/cdn-cgi/l/email-protection#a6c5c0d5c7c5e6ceced588c1c9d0"><span class="__cf_email__" data-cfemail="503336233133103838237e373f26">[email protected]</span></a>.
    All testimony and printed material submitted for the meeting are 
part of the official meeting record and will be uploaded to the CFSAC 
Web site and made available for public inspection. Testimony and 
materials submitted should not include any sensitive personal 
information, such as a person's social security number; date of birth; 
driver's license number, State identification number or foreign country 
equivalent; passport number; financial account number; or credit or 
debit card number. Sensitive health information, such as medical 
records or other individually identifiable health information, or any 
non-public corporate or trade association information, such as trade 
secrets or other proprietary information also should be excluded from 
any materials submitted.

    Dated: March 18, 2011.
Wanda K. Jones,
Executive Secretary, Chronic Fatigue Syndrome Advisory Committee.
[FR Doc. 2011-6702 Filed 3-21-11; 8:45 am]
BILLING CODE 4150-42-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>